editasmedicine.com - Nilai perusahaan marang pendapatan EDIT

Logo perusahaan publik Editas Medicine Inc (EDIT)

Editas Medicine, Inc. (EDIT) is implementing robotic CRISPR platforms and AI to automate bio-screening, thereby eliminating human error. This enterprise value-to-revenue chart reflects the current market valuation of the business, where the metric stands at 2899.46. The company aims for leadership in DNA mutation correction by developing radical therapies. Meanwhile, its developments are shielded from export risks, maintaining a stable scientific and clinical environment.

EDIT editasmedicine.com: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Editas (EDIT)

- rincian nilai pasar emiten:
- informasi babagan dhuwit lan arus kas:
Pambiji fundamental perusahaan:EDIT (editasmedicine.com)
Barang utama Editas Medicine Inc

This indicator determines the market value of the business, accounting for net debt per unit of generated revenue. The calculation combines market capitalization and liabilities, eliminating the influence of financing structure on the efficiency assessment. The price action of the EV/Sales multiple allows for the timely identification of asset accumulation phases. For Editas Medicine, Inc. (EDIT), such transparency is critical when implementing costly ESG standards. The greening of genome editing centers impacts capital expenditures, which is reflected in the final ratio.

Analisis pesaing

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|SLN - Rasio total nilai perusahaan marang pendapatan|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan